Zhongchao (ZCMD) News Today → CEO of Biggest AI Chipmaker Just Dropped a Bombshell… (From Banyan Hill Publishing) (Ad) Free ZCMD Stock Alerts $1.51 +0.06 (+4.14%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16 at 2:16 AM | americanbankingnews.comReviewing Zhongchao (NASDAQ:ZCMD) & iHuman (NYSE:IH)May 11, 2024 | americanbankingnews.comZhongchao Inc. (NASDAQ:ZCMD) Short Interest Up 337.3% in AprilMay 3, 2024 | finance.yahoo.comZhongchao Full Year 2023 Earnings: US$4.35 loss per share (vs US$1.13 loss in FY 2022)April 19, 2024 | investorplace.comWhy Is Zhongchao (ZCMD) Stock Up 103% Today?April 16, 2024 | morningstar.comZHONGCHAO Inc Ordinary Shares - Class AApril 5, 2024 | msn.comAltice USA, Genfit, Brooge Energy among premarket losers' packApril 4, 2024 | investorplace.comWhy Is Zhongchao (ZCMD) Stock Up 40% Today?March 12, 2024 | prnewswire.comZhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of MedicationsMarch 5, 2024 | msn.comWhy Paymentus Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving PremarketMarch 5, 2024 | investorplace.comWhy Is Zhongchao (ZCMD) Stock Up 15% Today?February 29, 2024 | marketbeat.comTrading was temporarily halted for "ZCMD" at 07:02 PM with a stated reason of "News pending."February 27, 2024 | prnewswire.comZhongchao Inc. Announces 1-for-10 Share ConsolidationDecember 28, 2023 | finance.yahoo.comZhongchao First Half 2023 Earnings: US$0.18 loss per share (vs US$0.004 profit in 1H 2022)December 11, 2023 | marketbeat.comTrading was temporarily halted for "ZCMD" at 12:12 PM with a stated reason of "LULD pause."December 11, 2023 | marketbeat.comTrading was temporarily halted for "ZCMD" at 10:12 AM with a stated reason of "LULD pause."December 11, 2023 | finance.yahoo.comZhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer TreatmentsDecember 11, 2023 | marketbeat.comTrading was temporarily halted for "ZCMD" at 09:12 AM with a stated reason of "LULD pause."November 30, 2023 | marketbeat.comTrading was temporarily halted for "ZCMD" at 11:11 AM with a stated reason of "LULD pause."October 23, 2023 | finance.yahoo.comZhongchao Inc. Launches Breast Cancer Follow-up Visit and Health Management Patient Guide Program on Breast Cancer Awareness DaySeptember 25, 2023 | finance.yahoo.comZhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer PatientsAugust 24, 2023 | finance.yahoo.comZhongchao Inc. Announces Serving over 10,000 Breast Cancer Patients with Its Comprehensive Disease ManagementJuly 11, 2023 | finance.yahoo.comZhongchao Inc. Partners with Ximalaya to Launch the First Audio Course Series for Cancer EducationJune 12, 2023 | finance.yahoo.comZhongchao Inc. Launch Digital Online Education Platform for Common Diseases Clinical Diagnosis and TreatmentMay 12, 2023 | finance.yahoo.comZhongchao Inc. Announces Strategic Cooperation with XimalayaMay 8, 2023 | finance.yahoo.comZhongchao Inc. Announces Naiditawei® Enrolled as a Listed Online Procurement Drug in Ten Provinces(Districts, Cities) in ChinaApril 24, 2023 | finance.yahoo.comZhongchao Inc. Partners with a Public Health Foundation to Safeguard Cancer Patients' HealthMarch 30, 2023 | finance.yahoo.comZhongchao Inc. Announces Launch of Health Education Intelligent Content Production PlatformMarch 13, 2023 | finance.yahoo.comZhongchao Inc. Releases Survey Results for Bone Marrow Cancer Patient Services with More than 80% Patients Indicating Full SatisfactionFebruary 24, 2023 | ca.finance.yahoo.comZhongchao Inc. (ZCMD) Stock Historical Prices & Data - Yahoo FinanceFebruary 23, 2023 | finance.yahoo.comZhongchao Inc. Renews Partnership with Johnson & Johnson (China)February 13, 2023 | finance.yahoo.comZhongchao Inc. Announces the Application of ChatGPT for Its MDMOOC Platform to Assist Physicians in Clinic Decision Making and Improve Treatment EfficiencyFebruary 9, 2023 | msn.com11 Consumer Discretionary Stocks Moving In Thursday's Intraday SessionFebruary 8, 2023 | finance.yahoo.comZhongchao Inc. Announces the Application of ChatGPT to Elevate Patient Management Service Capabilities and ExperienceJanuary 31, 2023 | finance.yahoo.comZhongchao Inc. Announces Introduction of Indian Anti-influenza Drugs to ChinaJanuary 19, 2023 | finance.yahoo.comZhongchao Inc. Launches Medication Management Assistance Mini Program to Facilitate Cancer TreatmentJanuary 4, 2023 | finance.yahoo.comZhongchao Inc. Announces Drug Distributorship in China of Indian Generic Drugs of Natco Pharma LimitedDecember 18, 2022 | finance.yahoo.comZhongchao First Half 2022 Earnings: EPS: US$0.004 (vs US$0.04 in 1H 2021)December 5, 2022 | finance.yahoo.comZhongchao Inc. Established SID Liver Cancer Comprehensive-Disciplinary Physician Education PlatformNovember 3, 2022 | finance.yahoo.comZhongchao Inc.'s China Operating Entity, Chongqing Xinjiang Pharmaceutical Co., Ltd. Obtained Pharmaceutical Trade and Medical Device Operation Licenses, Ready to Enter Into Pharmaceuticals Circulation MarketOctober 25, 2022 | marketbeat.comTrading was temporarily halted for "ZCMD" at 09:10 AM with a stated reason of "LULD pause."September 28, 2022 | finance.yahoo.comZhongchao Inc. Establishes Chongqing Xinjiang Pharmaceutical Co., Ltd. to Improve Patient Access to MedicationsSeptember 19, 2022 | reuters.comZCMD.OQ - Zhongchao Inc | Stock Price & Latest News | ReutersSeptember 15, 2022 | finance.yahoo.comZhongchao Inc. Establishes Zhixun Internet Hospital to Provide Patient with Management Services Focusing on the Oncology and Other Major DiseasesSeptember 1, 2022 | finance.yahoo.comZhongchao Inc. Announces its New Strategy Extension Focusing on the Oncology and Other Major Disease ManagementJune 2, 2022 | benzinga.comZHONGCHAO (NASDAQ:ZCMD), Earnings Estimates, EPS, and RevenueJune 2, 2022 | benzinga.comZHONGCHAO (NASDAQ:ZCMD), Short Interest ReportMay 9, 2022 | finance.yahoo.comZhongchao Inc. Reports the Fiscal Year 2021 Financial ResultsMarch 21, 2022 | finance.yahoo.comCould The Market Be Wrong About Zhongchao Inc. (NASDAQ:ZCMD) Given Its Attractive Financial Prospects?March 14, 2022 | msn.comU.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.69%March 11, 2022 | msn.comU.S. shares lower at close of trade; Dow Jones Industrial Average down 0.69% Get Zhongchao News Delivered to You Automatically Sign up to receive the latest news and ratings for ZCMD and its competitors with MarketBeat's FREE daily newsletter. Email Address He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (Ad)For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market. Click for his six specific AI stock in the crosshairs ZCMD Media Mentions By Week ZCMD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZCMD News Sentiment▼0.000.42▲Average Medical News Sentiment ZCMD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZCMD Articles This Week▼10▲ZCMD Articles Average Week Get Zhongchao News Delivered to You Automatically Sign up to receive the latest news and ratings for ZCMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Mustang Bio News Aravive News Avalon GloboCare News Biophytis News Innovative Eyewear News Agile Therapeutics News Quoin Pharmaceuticals News NovaBay Pharmaceuticals News iSpecimen News Cyclacel Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ZCMD) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaBill Gates is all about this tiny $2 stockTimothy SykesThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsUrgent Nvidia WarningAltimetryCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics41 banks launch ‘crypto dollar’Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zhongchao Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
